T42.8X3

Clinical Causes: Intentional overdose or misuse of antiparkinsonism medications Deliberate poisoning as an act of assault Accidental ingestion of a large quantity of central muscle-tone depressants Use of these drugs in suicide attempts or self-harm Distribution of medication to others without medical guidance

Key Symptoms: Dizziness or lightheadedness Muscle weakness or fatigue Drowsiness or sedation Respiratory depression or difficulty breathing Loss of coordination or impaired motor skills Altered mental state, confusion, or disorientation Nausea or vomiting Unconsciousness or coma in severe cases Cardiovascular abnormalities such as irregular heartbeat

Diagnosis Path: Diagnosis involves a thorough medical history review, including medication usage, and physical examination. Laboratory tests such as blood and urine analysis can detect the presence and levels of the specific drugs involved. In some cases, additional investigations like arterial blood gases or electrocardiograms (ECGs) may be performed to assess the extent of toxicity and its effects on vital functions. Poisoning is recognized based on clinical symptoms and confirmed through toxicology testing, especially in suspected cases of assault.

Treatment Protocols: Treatment focuses on stabilizing the patient and preventing further absorption of the toxins. Initial management may include supportive care such as maintaining airway patency, breathing, and circulation. Activated charcoal might be administered to reduce drug absorption if the poisoning was recent. In certain cases, specific antidotes—if available—or medications to counteract the central depressant effects are used. Continuous monitoring of vital signs and neurological status is essential. Severe cases may require hospitalization, IV fluids, and advanced interventions like mechanical ventilation. Psychological support and counseling may be necessary in cases related to deliberate poisoning to address underlying issues and prevent recurrence.